![]()
Gilead Sciences has addressed the big question surrounding just how much its drug remdesivir will cost for COVID-19 treatment, after positive early trials indicated the medicine could hasten recovery during the pandemic. The announcement will come as a disappointment to anybody hoping coronavirus treatment might be given free of charge, though Gilead argues that it’s pricing remdesivir aggressively. Initial trials … Continue reading![]()
Post a Comment